These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38177728)

  • 1. Interpretable model of CRISPR-Cas9 enzymatic reactions.
    Wen DJ; Theodoris CV
    Nat Comput Sci; 2023 Dec; 3(12):1011-1012. PubMed ID: 38177728
    [No Abstract]   [Full Text] [Related]  

  • 2. CRISPR-Cas9-mediated multiplex gene editing in CAR-T cells.
    Liu X; Zhang Y; Cheng C; Cheng AW; Zhang X; Li N; Xia C; Wei X; Liu X; Wang H
    Cell Res; 2017 Jan; 27(1):154-157. PubMed ID: 27910851
    [No Abstract]   [Full Text] [Related]  

  • 3. CRISPR/Cas9-Mediated Genome Editing of Trichoderma reesei.
    Zou G; Zhou Z
    Methods Mol Biol; 2021; 2234():87-98. PubMed ID: 33165782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutting back malaria: CRISPR/Cas9 genome editing of Plasmodium.
    Lee MCS; Lindner SE; Lopez-Rubio JJ; Llinás M
    Brief Funct Genomics; 2019 Sep; 18(5):281-289. PubMed ID: 31365053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sharpening the Scissors: Mechanistic Details of CRISPR/Cas9 Improve Functional Understanding and Inspire Future Research.
    Raper AT; Stephenson AA; Suo Z
    J Am Chem Soc; 2018 Sep; 140(36):11142-11152. PubMed ID: 30160947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid genome editing by CRISPR-Cas9-POLD3 fusion.
    Reint G; Li Z; Labun K; Keskitalo S; Soppa I; Mamia K; Tolo E; Szymanska M; Meza-Zepeda LA; Lorenz S; Cieslar-Pobuda A; Hu X; Bordin DL; Staerk J; Valen E; Schmierer B; Varjosalo M; Taipale J; Haapaniemi E
    Elife; 2021 Dec; 10():. PubMed ID: 34898428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marker-free genome editing in Ustilago trichophora with the CRISPR-Cas9 technology.
    Huck S; Bock J; Girardello J; Gauert M; Pul Ü
    RNA Biol; 2019 Apr; 16(4):397-403. PubMed ID: 29996713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR/Cas9 in plants: at play in the genome and at work for crop improvement.
    Hussain B; Lucas SJ; Budak H
    Brief Funct Genomics; 2018 Sep; 17(5):319-328. PubMed ID: 29912293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome editing: A perspective on the application of CRISPR/Cas9 to study human diseases (Review).
    Rodríguez-Rodríguez DR; Ramírez-Solís R; Garza-Elizondo MA; Garza-Rodríguez ML; Barrera-Saldaña HA
    Int J Mol Med; 2019 Apr; 43(4):1559-1574. PubMed ID: 30816503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-viral delivery systems for CRISPR/Cas9-based genome editing: Challenges and opportunities.
    Li L; Hu S; Chen X
    Biomaterials; 2018 Jul; 171():207-218. PubMed ID: 29704747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome Editing in Mice Using CRISPR/Cas9 Technology.
    Hall B; Cho A; Limaye A; Cho K; Khillan J; Kulkarni AB
    Curr Protoc Cell Biol; 2018 Dec; 81(1):e57. PubMed ID: 30178917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Single Administration of CRISPR/Cas9 Lipid Nanoparticles Achieves Robust and Persistent In Vivo Genome Editing.
    Finn JD; Smith AR; Patel MC; Shaw L; Youniss MR; van Heteren J; Dirstine T; Ciullo C; Lescarbeau R; Seitzer J; Shah RR; Shah A; Ling D; Growe J; Pink M; Rohde E; Wood KM; Salomon WE; Harrington WF; Dombrowski C; Strapps WR; Chang Y; Morrissey DV
    Cell Rep; 2018 Feb; 22(9):2227-2235. PubMed ID: 29490262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly Efficient Targeted Gene Editing in Upland Cotton Using the CRISPR/Cas9 System.
    Zhu S; Yu X; Li Y; Sun Y; Zhu Q; Sun J
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30275376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR-Cas9 genome editing induces a p53-mediated DNA damage response.
    Haapaniemi E; Botla S; Persson J; Schmierer B; Taipale J
    Nat Med; 2018 Jul; 24(7):927-930. PubMed ID: 29892067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR-Cas9 hits its target in amyloidosis.
    Carvalho T
    Nat Med; 2022 Dec; 28(12):2438. PubMed ID: 36224265
    [No Abstract]   [Full Text] [Related]  

  • 16. Plant Tissue Culture: A Battle Horse in the Genome Editing Using CRISPR/Cas9.
    Loyola-Vargas VM; Avilez-Montalvo RN
    Methods Mol Biol; 2018; 1815():131-148. PubMed ID: 29981117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR/Cas9 genome editing.
    Zhang S; Shen J; Li D; Cheng Y
    Theranostics; 2021; 11(2):614-648. PubMed ID: 33391496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. sgRNA Sequence Motifs Blocking Efficient CRISPR/Cas9-Mediated Gene Editing.
    Graf R; Li X; Chu VT; Rajewsky K
    Cell Rep; 2019 Jan; 26(5):1098-1103.e3. PubMed ID: 30699341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conditional CRISPR-Cas Genome Editing in
    Bahuguna S; Redhai S; Zhou J; Wang T; Port F; Boutros M
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulating CRISPR/Cas9 Function through Conditional Guide RNA Control.
    Brown W; Zhou W; Deiters A
    Chembiochem; 2021 Jan; 22(1):63-72. PubMed ID: 32833316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.